# Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali

> **NCT01645254** · PHASE1 · UNKNOWN · sponsor: **University of Bamako** · enrollment: 24 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Argemone mexicana

## Key facts

- **NCT ID:** NCT01645254
- **Lead sponsor:** University of Bamako
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2012-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01645254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01645254, "Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01645254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*